All News #Library
Biotech
Vapendavir Selected For ICAR 2026 Oral Presentation
19 Mar 2026 //
PR NEWSWIRE
Altesa BioSciences Closes $75M Oversubscribed Series B
19 Feb 2026 //
PR NEWSWIRE
Altesa Bio Shows Vapendavir Benefits In Rhinovirus COPD Study
28 Sep 2025 //
PR NEWSWIRE

Market Place
Sourcing Support